The AESOP Trial: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Obeticholic Acid in Patients with Primary Sclerosing Cholangitis

被引：0

作者：

Kowdley, Kris V. ^{[2
]}

Bowlus, Christopher L. ^{[3
]}

Levy, Cynthia ^{[4
]}

Vuppalanchi, Raj ^{[5
]}

Floreani, Annarosa ^{[6
]}

Andreone, Pietro ^{[7
]}

LaRusso, Nicholas F. ^{[8
]}

Shrestha, Roshan ^{[9
]}

Trotter, James ^{[1
]}

Goldberg, David S. ^{[10
]}

Rushbrook, Simon ^{[11
]}

Hirschfield, Gideon M. ^{[12
]}

Van Biene, Courtney ^{[13
]}

Pencek, Richard ^{[13
]}

MacConell, Leigh ^{[13
]}

Shapiro, David ^{[13
]}

机构：

[1] Baylor Univ, Div Transplant Hepatol, Dallas, TX USA

[2] Swedish Med Ctr, Seattle, WA USA

[3] Univ Calif Davis, Div Gastroenterol & Hepatol, Sacramento, CA 95817 USA

[4] Univ Miami, Miller Sch Med, Div Hepatol, Miami, FL 33136 USA

[5] Indiana Univ Sch Med, Indianapolis, IN 46202 USA

[6] Univ Padua, Padua, Italy

[7] Univ Bologna, Bologna, Italy

[8] Mayo Clin, Dept Med, Div Gastroenterol & Hepatol, Rochester, MN USA

[9] Piedmont Transplant Inst, Dept Transplantat, Atlanta, GA USA

[10] Univ Penn, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA

[11] Norwich Med Sch, Fac Med & Hlth Sci, Norwich, Norfolk, England

[12] Univ Birmingham, Ctr Liver Res, NIHR BRU, Birmingham, W Midlands, England

[13] Intercept Pharmaceut Inc, San Diego, CA USA

来源：

HEPATOLOGY | 2017年 / 66卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

LB-2

引用

页码：1254A / 1255A

页数：2

共 50 条

[1] THE AESOP TRIAL: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY OF OBETICHOLIC ACID IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS
Larusso, N. F.
Bowlus, C. L.
Levy, C.
Vuppalanchi, R.
Floreani, A.
Andreone, P.
Srestha, R.
Trotter, J.
Goldberg, D.
Rushbrook, S.
Hirschfield, G. M.
Van Biene, C.
Penceck, R.
Macconell, L.
David, S.
DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E67 - E67
[2] Fenofibrate in primary sclerosing cholangitis; a randomized, double-blind, placebo-controlled trial
Hatami, Behzad
Mosala, Mozhde
Hassani, Amir Hossein
Ardakani, Mohammad Javad Ehsani
Gholami, Samira
Zali, Mohammad Reza
PHARMACOLOGY RESEARCH & PERSPECTIVES, 2022, 10 (04):
[3] A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis
Kowdley, Kris, V
Vuppalanchi, Raj
Levy, Cynthia
Floreani, Annarosa
Andreone, Pietro
LaRusso, Nicholas F.
Shrestha, Roshan
Trotter, James
Goldberg, David
Rushbrook, Simon
Hirschfield, Gideon M.
Schiano, Thomas
Jin, Yuying
Pencek, Richard
MacConell, Leigh
Shapiro, David
Bowlus, Christopher L.
JOURNAL OF HEPATOLOGY, 2020, 73 (01) : 94 - 101
[4] A double-blind, placebo-controlled, randomized study of infliximab in primary sclerosing cholangitis
Hommes, Daan W.
Erkelens, Willernien
Ponsioen, Cyriel
Stokkers, Pieter
Raws, Erik
van der Spek, Miram
Ten Kate, Fiebo
van Deventer, Sander J.
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2008, 42 (05) : 522 - 526
[5] URSODEOXYCHOLIC ACID IN PRIMARY SCLEROSING CHOLANGITIS - A DOUBLE-BLIND PLACEBO CONTROLLED TRIAL
LO, SK
HERRMANN, R
CHAPMAN, RW
FLEMING, KA
SHEARMAN, J
CUSICK, P
DOOLEY, JS
HEPATOLOGY, 1992, 16 (04) : A92 - A92
[6] High-dose ursodeoxycholic acid in primary sclerosing cholangitis a randomised double-blind placebo-controlled trial
Bansi, D
Christie, J
Fleming, K
Chapman, R
GASTROENTEROLOGY, 1996, 110 (04) : A1146 - A1146
[7] A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
Nevens, F.
Andreone, P.
Mazzella, G.
Strasser, S. I.
Bowlus, C.
Invernizzi, P.
Drenth, J. P. H.
Pockros, P. J.
Regula, J.
Beuers, U.
Trauner, M.
Jones, D. E.
Floreani, A.
Hohenester, S.
Luketic, V.
Shiffman, M.
van Erpecum, K. J.
Vargas, V.
Vincent, C.
Hirschfield, G. M.
Shah, H.
Hansen, B.
Lindor, K. D.
Marschall, H-U
Kowdley, K. V.
Hooshmand-Rad, R.
Marmon, T.
Sheeron, S.
Pencek, R.
MacConell, L.
Pruzanski, M.
Shapiro, D.
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (07): : 631 - 643
[8] Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis:: A randomized placebo-controlled trial
Färkkilä, M
Karvonen, AL
Nurmi, H
Nuutinen, H
Taavitsainen, M
Pikkarainen, P
Kärkkäinen, P
HEPATOLOGY, 2004, 40 (06) : 1379 - 1386
[9] REGENERATE: A PHASE 3, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED MULTICENTER STUDY OF OBETICHOLIC ACID THERAPY FOR NONALCOHOLIC STEATOHEPATITIS
Ratziu, V.
Sanyal, A. J.
MacConell, L.
Shringarpure, R.
Marmon, T.
Shapiro, D.
Younossi, Z. M.
JOURNAL OF HEPATOLOGY, 2016, 64 : S294 - S295
[10] Regenerate: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Multicenter Study of Obeticholic Acid Therapy for Nonalcoholic Steatohepatitis
Younossi, Zobair M.
Ratziu, Vlad
Sanyal, Arun J.
MacConell, Leigh
Shringarpure, Reshma
Marmon, Tonya
Shaprio, David
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S1273 - S1273

← 1 2 3 4 5 →